Impacto 2.0 for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a preliminary efficacy trial that will examine whether Impacto 2.0 produces higher rates of biochemically verified smoking abstinence among Hispanic adults across Texas compared to the NCI quitSTART app. The primary objective is to evaluate the preliminary efficacy of Impacto 2.0 in reducing smoking, tobacco withdrawal, and craving. One hundred Hispanic adults who smoke will be recruited across Texas and followed remotely over an 8-week intervention period with a 3-month post-quit follow-up.
Are You a Good Fit for This Trial?
This trial is for Hispanic adults in Texas who currently smoke cigarettes. Participants must be willing to try quitting smoking and able to use a mobile app. The study does not specify other major health exclusions.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Impacto 2.0
Trial Overview
The trial compares two smartphone apps—Impacto 2.0 and the NCI quitSTART app—to see which helps more Hispanic adults in Texas quit smoking over an 8-week period, with follow-up after three months.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will use the Impacto 2.0 smartphone application for 8 weeks.
Participants will use the National Cancer Institute's quitSTART smartphone application for 8 weeks.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Michael J. Zvolensky, Ph.D.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.